American Century Companies’s Nurix Therapeutics NRIX Stock Holding History

American Century Companies's NRIX Position: Q2 2026 in Review

American Century Companies reduced its Nurix Therapeutics (NRIX) stake by 78% in Q2 2026, selling an estimated $1.03M and leaving 17,335 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #2625.

American Century Companies first reported a position in NRIX in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.21M in Q1 2026. 194 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

• American Century Companies held 17,335 shares of Nurix Therapeutics worth $421K as of Q2 2026.
• American Century Companies sold 60,722 Nurix Therapeutics shares in Q2 2026, an estimated $1.03M.
• Nurix Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2625 holding.
• American Century Companies first reported a position in Nurix Therapeutics in Q4 2022 and has held it in 11 quarters since.
• American Century Companies's Nurix Therapeutics position peaked at $1.21M in Q1 2026.
• 194 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.